Product Manager
Thermo Fisher Scientific
Stacie Lupo, MBA, MLS(ASCP)CM, is a dedicated professional with a diverse academic and professional background. She holds a dual Bachelor of Science in Biology and Clinical Laboratory Science from the prestigious Oregon Health & Science University. In addition to her scientific prowess, Stacie possesses a Master of Business Administration from the renowned University of Utah David Eccles School of Business. This unique combination of scientific and business acumen has positioned her as a pivotal figure in the field of molecular pathology and laboratory management.
Currently serving as a Global Product Manager within the Life Sciences Group at Thermo Fisher Scientific, Stacie is critical in shaping product portfolio and strategy for molecular automated workflow solutions. Her responsibilities encompass understanding market needs, conducting competitive analysis, and collaborating with cross-functional teams to develop and deliver innovative molecular pathology solutions to meet the evolving needs of laboratories and diagnostic professionals worldwide. Stacie leverages her scientific knowledge and strategic business insights to drive product innovation and market success.
Before her role at Thermo Fisher Scientific, Stacie was a Laboratory Manager for Molecular and Cytogenetics at Legacy Health System in Portland, Oregon. In this capacity, she was responsible for overseeing the day-to-day operations of the laboratory, ensuring compliance with regulatory standards, and implementing cutting-edge molecular pathology techniques. Her tenure at Legacy Health System demonstrated her commitment to advancing laboratory practices and delivering quality patient care.
Stacie's dual expertise in science and business has led to a career marked by transformative contributions to molecular pathology. Her dedication to innovation, combined with a strong track record of leadership, makes her a valuable asset to the Association for Molecular Pathology community as she continues to shape the future of diagnostics and healthcare through her work at Thermo Fisher Scientific.